Recovery Factor
The recovery factor is a risk metric equal to a strategy's net profit divided by the absolute value of its maximum drawdown, measuring how many times over the strategy earned back the depth of its worst peak-to-trough loss.
Quick answer: The recovery factor is a risk metric equal to a strategy's net profit divided by the absolute value of its maximum drawdown, measuring how many times over the strategy earned back the depth of its worst peak-to-trough loss.
In simple words
The recovery factor asks a blunt question: across the whole backtest, how much total profit did the strategy make for each unit of its worst drawdown. A recovery factor of 5 means the net profit was five times the size of the deepest fall. Higher is better, because it means the strategy comfortably out-earned the pain of its worst moment, though like all drawdown-based metrics it leans on that single worst episode.
Purpose
The recovery factor exists to express profitability in units of the worst loss endured, giving a quick sense of whether a strategy's total reward justified its deepest historical pain.
Professional explanation
Total profit measured in worst-drawdown units
The recovery factor divides net profit over the full period by the absolute maximum drawdown. Unlike Calmar, which uses annualised growth (CAGR) in the numerator, the recovery factor uses total net profit, so it is not annualised and grows mechanically with the length of the backtest. A ten-year test will tend to show a higher recovery factor than a two-year test of the same strategy simply because more profit has accumulated against a maximum drawdown that grows far more slowly. This makes the recovery factor length-dependent and not directly comparable across different test durations.
Relationship to the Calmar ratio
Recovery factor and Calmar are close relatives that share the same maximum-drawdown denominator but differ in the numerator: total net profit versus annualised return. Because of this, Calmar is roughly the recovery factor divided by the number of years, so a recovery factor of 6 over three years corresponds to a Calmar near 2 only loosely, since profit and CAGR are not linearly related. When comparing strategies of different lengths, Calmar is the fairer measure; the recovery factor is most useful within a fixed observation window.
What a high recovery factor does and does not prove
A high recovery factor indicates the strategy generated substantial profit relative to its worst fall, which is encouraging for survivability. But it inherits every weakness of maximum drawdown: it rests on one historical episode that understates the true worst case, and it can only look better as the window lengthens. A high recovery factor from a long backtest that never encountered the strategy's stress regime is a particularly seductive trap, combining accumulated profit with an artificially shallow drawdown.
Sensitivity to the sequence and the sample
Because the denominator is the maximum drawdown, the recovery factor is highly sensitive to the ordering of returns and to whether the sample contained a crisis. The same trades in a different sequence can deepen the maximum drawdown and slash the recovery factor even though total profit is unchanged. This path dependence means a single reported recovery factor is a point estimate from one particular history; Monte Carlo resampling reveals how much it would vary across plausible alternative orderings.
Where it fits in a metric suite
The recovery factor is a useful quick screen but never a standalone verdict. It pairs naturally with Calmar (its annualised sibling), with the maximum drawdown and its duration, and with a profit factor that describes trade-level efficiency. In a robust evaluation it flags strategies whose profits are large relative to their worst pain, but the decision to deploy still rests on out-of-sample evidence, a stress-tested drawdown, and confirmation that the profit is net of realistic Indian-market costs.
Formula
Recovery factor = Net profit ÷ |Maximum drawdown|
Net profit = total profit over the whole test period (in currency or as a fraction of starting capital, used consistently with the drawdown), Maximum drawdown = the largest peak-to-trough decline over the same period, taken as a positive absolute value. It is not annualised, so it grows with the length of the backtest and is not comparable across different test durations.
Recovery factor vs Calmar ratio
| Aspect | Recovery factor | Calmar ratio |
|---|---|---|
| Numerator | Total net profit | CAGR (annualised) |
| Denominator | Maximum drawdown | Maximum drawdown |
| Annualised | No | Yes |
| Comparable across test lengths | No, grows with time | Yes |
| Shared weakness | Rests on one drawdown episode | Rests on one drawdown episode |
Practical example
Illustrative example (Indian market)
A Nifty positional strategy starts with ₹5,00,000 and ends the backtest with a net profit of ₹4,50,000, having suffered a worst peak-to-trough drawdown of ₹1,50,000 along the way. Recovery factor = 4,50,000 ÷ 1,50,000 = 3.0, meaning the strategy earned three times the depth of its worst fall over the test. If this covered six years, an otherwise identical three-year sub-period would likely show a lower recovery factor near 1.5, illustrating how the metric mechanically rises with test length and so must be compared only within a fixed window.
For an NSE strategy, always confirm the net profit in the recovery factor is genuinely net of STT, brokerage, GST and slippage; a gross-profit numerator over an unrealistically shallow in-sample maximum drawdown can produce a flattering recovery factor that collapses once real frictions and a stress period are included.
Advantages
- Expresses total reward in intuitive units of the worst loss endured
- Quick screen for whether profit justified the deepest pain
- Simple to compute from net profit and maximum drawdown
- Complements Calmar as its non-annualised sibling
- Higher values flag strategies that comfortably out-earned their worst fall
Limitations
- Not annualised, so it grows with test length and is not comparable across durations
- Its blind spot: rests on the single maximum drawdown, which understates the true worst case
- Highly sensitive to return sequence and whether the sample contained a crisis
- Can be inflated by a long, benign window that missed the stress regime
- Ignores the frequency and duration of drawdowns
- Meaningless unless the profit is net of realistic costs
Why it matters in practice
- It is a fast survivability screen within a fixed observation window
- Its length dependence makes Calmar the fairer cross-strategy comparison
Common mistakes
- Comparing recovery factors across backtests of different lengths
- Treating a high recovery factor as evidence of a robust edge on its own
- Using gross profit instead of profit net of costs in the numerator
- Trusting a recovery factor from a window that never hit the strategy's stress regime
- Confusing the recovery factor with the annualised Calmar ratio
- Ignoring that the denominator understates the true future worst drawdown
Professional usage
Practitioners use the recovery factor as a fast, intuitive screen but convert to Calmar when comparing strategies of different lengths, because the recovery factor's growth with time makes raw comparison unfair. They insist the numerator be net profit after realistic costs, treat the maximum-drawdown denominator as an optimistic single sample, and cross-check with a Monte Carlo distribution to see how the factor would vary across alternative return orderings. Like all drawdown ratios, it informs the deployment decision but never settles it alone.
Key takeaways
- Recovery factor is net profit divided by the absolute maximum drawdown
- It shows how many times over a strategy earned back its worst fall
- It is not annualised, so it grows with test length and needs a fixed window to compare
- Calmar is its annualised sibling and is fairer across differing durations
- It inherits maximum drawdown's blind spot and must use cost-net profit
Frequently asked questions
What is the recovery factor?
How is the recovery factor different from the Calmar ratio?
Why does the recovery factor grow with a longer backtest?
What is a good recovery factor?
Can I compare recovery factors across strategies of different lengths?
Does the recovery factor prove a strategy is robust?
Should the numerator be gross or net profit?
How does return sequence affect the recovery factor?
How does the recovery factor relate to Calmar numerically?
Can the recovery factor be negative?
Why is a high recovery factor from a benign period misleading?
Does the recovery factor consider drawdown frequency?
Is the recovery factor useful at all given its flaws?
How can I make the recovery factor more trustworthy?
Voice search & related questions
Natural-language questions people ask about Recovery Factor.
What is the recovery factor in simple terms?
How is it different from Calmar?
Is a higher recovery factor always better?
Why does test length change the recovery factor?
Should I trust a high recovery factor alone?
Does the recovery factor use profit before or after costs?
Sources & references
Last reviewed 11 July 2026. Educational content only — not investment advice. Markets and rules change; verify current conventions with SEBI, NSE/BSE and your broker.